Graft-versus-host disease (GVHD) is a major risk factor for secondary malignancy after hematopoietic stem cell transplantation. Squamous cell carcinoma (SCC) of the skin and mucous membranes are especially frequent in this setting where aneuploidy and tetraploidy are associated with aggressive disease. The current study is directed at the mechanism of neoplasia in this setting. Unmanipulated keratinocytes from areas of oral GVHD in 9 patients showed tetraploidy in 10% to 46% of cells when examined by florescein in situ hybridization (FISH). Keratinocytes isolated from biopsy sites of GVHD but not from normal tissue showed even greater numbers of tetraploid cells (mean = 78%, range: 15%-85%; N = 9) after culture. To mimic the inflammatory pr...
Graft versus host disease (GVHD) is a refractory complication of allogeneic hematopoietic stem cell ...
Graft versus host reaction (GvH) following leukocytic transfusions occurred in a 34-year-old man wit...
Graft-versus-host disease (GVHD) can ccur in bone marrow-transplant recipients even when donor and h...
Graft-versus-host disease (GVHD) is a major risk factor for secondary malignancy after hematopoietic...
International audienceIn animal models, tissue stem cells were proposed to exhibit an unexpected lev...
BackgroundHematopoietic stem cell transplant is a crucial intervention to definitively treat many he...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in humans, following hematoablative t...
Acute graft-versus-host disease (GVHD) afflicts up to 80 % of all patients receiving an unrelated do...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in humans, following hematoablative t...
Allogeneic bone marrow transplantation (BMT) is the therapy of choice for a variety of malignant and...
The major histocompatibility complex (MHC) is the most important genomic region that contributes to ...
We hypothesized that chronic tissue stress due to interaction of alloreactive donor cells with host ...
Risk factors for graft-versus-host disease (GVHD) following allogeneic hematopoietic stem-cell trans...
The mechanisms responsible for skin lesions during acute graft-vs.-host disease (aGVHD) after alloge...
Graft-versus-host disease (GvHD) is a major complication following stem-cell or solid-organ transpla...
Graft versus host disease (GVHD) is a refractory complication of allogeneic hematopoietic stem cell ...
Graft versus host reaction (GvH) following leukocytic transfusions occurred in a 34-year-old man wit...
Graft-versus-host disease (GVHD) can ccur in bone marrow-transplant recipients even when donor and h...
Graft-versus-host disease (GVHD) is a major risk factor for secondary malignancy after hematopoietic...
International audienceIn animal models, tissue stem cells were proposed to exhibit an unexpected lev...
BackgroundHematopoietic stem cell transplant is a crucial intervention to definitively treat many he...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in humans, following hematoablative t...
Acute graft-versus-host disease (GVHD) afflicts up to 80 % of all patients receiving an unrelated do...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in humans, following hematoablative t...
Allogeneic bone marrow transplantation (BMT) is the therapy of choice for a variety of malignant and...
The major histocompatibility complex (MHC) is the most important genomic region that contributes to ...
We hypothesized that chronic tissue stress due to interaction of alloreactive donor cells with host ...
Risk factors for graft-versus-host disease (GVHD) following allogeneic hematopoietic stem-cell trans...
The mechanisms responsible for skin lesions during acute graft-vs.-host disease (aGVHD) after alloge...
Graft-versus-host disease (GvHD) is a major complication following stem-cell or solid-organ transpla...
Graft versus host disease (GVHD) is a refractory complication of allogeneic hematopoietic stem cell ...
Graft versus host reaction (GvH) following leukocytic transfusions occurred in a 34-year-old man wit...
Graft-versus-host disease (GVHD) can ccur in bone marrow-transplant recipients even when donor and h...